A quartet of firms from across the UK, Ireland and the US have advised on the successful acquisition of Irish Republic-based Covidien by US medical device maker Medtronic in a $42.9bn(£25.3bn) cash and shares deal.
The new combined firm, which will operate under the name Medtronic Plc, will have more than 87,000 employees, creating a competitor similar in size to the medical device business of industry leader Johnson & Johnson Co. The merged firm will be headquartered in Ireland, enabling it to take advantage of a lower corporate tax rate than in the US.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]